{"id":3356,"count":132,"description":"<strong>Kupte si l\u00e9ky na krevn\u00ed tlak online \u2014 blok\u00e1tory receptor\u016f pro angiotensin (ARB), ACE inhibitory, betablok\u00e1tory, blok\u00e1tory kalciov\u00fdch kan\u00e1l\u016f, diuretika, alfablok\u00e1tory, centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed l\u00e1tky, nitr\u00e1ty a specializovanou terapii plicn\u00ed hypertenze.<\/strong> Hypertenze je hlavn\u00ed modifikovatelnou p\u0159\u00ed\u010dinou c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody, ischemick\u00e9 choroby srde\u010dn\u00ed, srde\u010dn\u00edho selh\u00e1n\u00ed, chronick\u00e9ho onemocn\u011bn\u00ed ledvin a demence. Sm\u011brnice ESC\/ESH z roku 2018, ACC\/AHA z roku 2017 a AHA pro hypertenzi z roku 2024 stanovuj\u00ed <strong>systolick\u00fd TK &lt;130 mmHg<\/strong> jako hlavn\u00ed c\u00edl pro v\u011bt\u0161inu pacient\u016f se zaveden\u00fdm kardiovaskul\u00e1rn\u00edm onemocn\u011bn\u00edm, diabetem nebo chronick\u00fdm onemocn\u011bn\u00edm ledvin \u2014 <strong>ka\u017ed\u00fd pokles systolick\u00e9ho tlaku o 10 mmHg sni\u017euje v\u00fdskyt z\u00e1va\u017en\u00fdch kardiovaskul\u00e1rn\u00edch p\u0159\u00edhod p\u0159ibli\u017en\u011b o 20 % a c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody o ~27 %<\/strong> v populac\u00edch prim\u00e1rn\u00ed i sekund\u00e1rn\u00ed prevence. Volba l\u00e9ku z\u00e1vis\u00ed na v\u011bku, etniku, p\u0159idru\u017een\u00fdch onemocn\u011bn\u00edch, po\u0161kozen\u00ed c\u00edlov\u00fdch org\u00e1n\u016f, t\u011bhotenstv\u00ed a sn\u00e1\u0161enlivosti.<strong>Blok\u00e1tory receptor\u016f pro angiotensin (ARB)<\/strong> \u2014 prvn\u00ed volba u mlad\u0161\u00edch pacient\u016f, diabetik\u016f, po infarktu myokardu, u srde\u010dn\u00edho selh\u00e1n\u00ed se sn\u00ed\u017eenou ejek\u010dn\u00ed frakc\u00ed a u chronick\u00e9ho onemocn\u011bn\u00ed ledvin s proteinuri\u00ed. <a href=\"https:\/\/medsbase.com\/cs\/telma\/\">Telma<\/a> (telmisartan), <a href=\"https:\/\/medsbase.com\/cs\/valent\/\">Valent<\/a> (valsartan), <a href=\"https:\/\/medsbase.com\/cs\/cozartan\/\">Cozartan<\/a> (losartan), <a href=\"https:\/\/medsbase.com\/cs\/olmin\/\">Olmin<\/a> a <a href=\"https:\/\/medsbase.com\/cs\/olmeheal\/\">Olmeheal<\/a> (olmesartan), a <a href=\"https:\/\/medsbase.com\/cs\/irovel\/\">Irovel<\/a> (irbesartan) pokr\u00fdvaj\u00ed p\u011bt nej\u010dast\u011bji p\u0159edepisovan\u00fdch molekul ARB. Fixn\u00ed kombinace ARB+HCTZ \u2014 <a href=\"https:\/\/medsbase.com\/cs\/telma-h\/\">Telma H<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/valzaar-h\/\">Valzaar H<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/losatec-h\/\">Losatec H<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/cosart-h\/\">Cosart H<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/cozartan-h\/\">Cozartan H<\/a> \u2014 p\u0159edstavuj\u00ed terapii druh\u00e9ho kroku, kdy\u017e monoterapie nedos\u00e1hne c\u00edlov\u00fdch hodnot po 4\u20136 t\u00fddnech. ARB nezp\u016fsobuj\u00ed ka\u0161el (na rozd\u00edl od ACE inhibitor\u016f) a maj\u00ed minim\u00e1ln\u00ed riziko angioed\u00e9mu.<strong>ACE inhibitory<\/strong> \u2014 rovnocenn\u00e1 mo\u017enost prvn\u00ed volby jako ARB, s siln\u011bj\u0161\u00edmi d\u016fkazy u srde\u010dn\u00edho selh\u00e1n\u00ed a po infarktu myokardu. <a href=\"https:\/\/medsbase.com\/cs\/cardace\/\">Cardace<\/a> a <a href=\"https:\/\/medsbase.com\/cs\/ramisave\/\">Ramisave<\/a> (ramipril) nesou nejrozs\u00e1hlej\u0161\u00ed data sekund\u00e1rn\u00ed prevence (studie HOPE). <a href=\"https:\/\/medsbase.com\/cs\/enapril\/\">Enapril<\/a> (enalapril) a <a href=\"https:\/\/medsbase.com\/cs\/hypernil\/\">Hypernil<\/a> (lisinopril) jsou dlouhodob\u011b p\u016fsob\u00edc\u00ed alternativy s jednou denn\u00ed d\u00e1vkou. P\u0159i v\u00fdskytu such\u00e9ho ka\u0161le (5\u201315 % pacient\u016f) nebo p\u0159i anamn\u00e9ze angioed\u00e9mu zp\u016fsoben\u00e9ho ACE inhibitory p\u0159ejd\u011bte na ARB.<strong>Beta-blok\u00e1tory<\/strong> \u2014 prvn\u00ed volba p\u0159i sou\u010dasn\u00e9m v\u00fdskytu hypertenze s anginou pectoris, po infarktu myokardu, p\u0159i kontrole frekvence p\u0159i fibrilaci s\u00edn\u00ed nebo p\u0159i srde\u010dn\u00edm selh\u00e1n\u00ed se sn\u00ed\u017eenou ejek\u010dn\u00ed frakc\u00ed. <a href=\"https:\/\/medsbase.com\/cs\/atenheal\/\">Atenheal<\/a> (atenolol) a <a href=\"https:\/\/medsbase.com\/cs\/beloc\/\">Beloc<\/a> (metoprolol) jsou standardn\u00ed kardio-selektivn\u00ed volby. <a href=\"https:\/\/medsbase.com\/cs\/topme\/\">Topme<\/a> a <a href=\"https:\/\/medsbase.com\/cs\/topme-xl\/\">Topme XL<\/a> poskytuj\u00ed metoprolol sukcin\u00e1t (prodlou\u017een\u00e1 forma schv\u00e1len\u00e1 pro srde\u010dn\u00ed selh\u00e1n\u00ed). <a href=\"https:\/\/medsbase.com\/cs\/nebilong\/\">Nebilong<\/a> (nebivolol) p\u0159id\u00e1v\u00e1 oxid dusnat\u00fd zprost\u0159edkovanou vazodilataci \u2014 preferovan\u00fd u star\u0161\u00edch pacient\u016f s hypertenz\u00ed a obavami z erektiln\u00ed dysfunkce. <a href=\"https:\/\/medsbase.com\/cs\/carvego\/\">Carvego<\/a> (carvedilol) a <a href=\"https:\/\/medsbase.com\/cs\/lobet\/\">Lobet<\/a> (labetalol) nab\u00edzej\u00ed kombinovanou alfa+beta blok\u00e1du pro rezistentn\u00ed hypertenzi a hypertenzi v t\u011bhotenstv\u00ed. <a href=\"https:\/\/medsbase.com\/cs\/provanol\/\">Provanol<\/a> (propranolol) se pou\u017e\u00edv\u00e1 k profylaxi migr\u00e9ny a esenci\u00e1ln\u00edmu tremoru.<strong>Blok\u00e1tory kalciov\u00fdch kan\u00e1l\u016f (CCB)<\/strong> \u2014 prvn\u00ed volba u star\u0161\u00edch pacient\u016f, pacient\u016f \u010derno\u0161sk\u00e9ho afro-karibsk\u00e9ho p\u016fvodu, izolovan\u00e9 systolick\u00e9 hypertenze a Raynaudova fenom\u00e9nu. Dihydropyridinov\u00e9 CCB <a href=\"https:\/\/medsbase.com\/cs\/amlode\/\">Amlode<\/a> (amlodipin) a <a href=\"https:\/\/medsbase.com\/cs\/cardipin-retard\/\">Cardipin Retard<\/a> (nifedipin retard) jsou c\u00e9vn\u011b selektivn\u00edmi hlavn\u00edmi l\u00e9ky. Nedihydropyridiny <a href=\"https:\/\/medsbase.com\/cs\/dilvas\/\">Dilvas<\/a> (diltiazem) a <a href=\"https:\/\/medsbase.com\/cs\/tachyra\/\">Tachyra<\/a> (verapamil) sni\u017euj\u00ed srde\u010dn\u00ed frekvenci krom\u011b krevn\u00edho tlaku \u2014 u\u017eite\u010dn\u00e9 pro kontrolu frekvence p\u0159i fibrilaci s\u00edn\u00ed a supraventrikul\u00e1rn\u00ed tachykardii, ale nikdy je nekombinujte s beta-blok\u00e1torem (riziko srde\u010dn\u00edho bloku).<strong>Diuretika<\/strong> \u2014 thiazidy jako <a href=\"https:\/\/medsbase.com\/cs\/hydrocl\/\">Hydrocl<\/a> (hydrochlorothiazid) jsou druhou nebo t\u0159et\u00ed volbou v postupn\u011b se zvy\u0161uj\u00edc\u00ed terapii. Kli\u010dkov\u00e1 diuretika jsou vyhrazena pro hypertenzi komplikovanou srde\u010dn\u00edm selh\u00e1n\u00edm nebo CKD st\u00e1diem 4\u20135. Indapamid a chlortalidon jsou dlouhodob\u011b p\u016fsob\u00edc\u00ed thiazid\u016fm podobn\u00e9 l\u00e1tky preferovan\u00e9 podle recentn\u00edch doporu\u010den\u00ed pro kardiovaskul\u00e1rn\u00ed v\u00fdsledky (ALLHAT, HYVET).<strong>Alfa-blok\u00e1tory a centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed l\u00e1tky<\/strong> \u2014 vyhrazeny pro rezistentn\u00ed hypertenzi nebo specifick\u00e9 komorbidity. <a href=\"https:\/\/medsbase.com\/cs\/prazopill-xl\/\">Prazopill XL<\/a> (prazosin XL) pokr\u00fdv\u00e1 feochromocytom, no\u010dn\u00ed m\u016fry u PTSD a BPH s hypertenz\u00ed. <a href=\"https:\/\/medsbase.com\/cs\/clodict\/\">Clodict<\/a> (klonidin) je centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed agonista alfa-2 pro rezistentn\u00ed hypertenzi a ADHD \u2014 nikdy nep\u0159eru\u0161ujte n\u00e1hle (riziko rebound hypertenzn\u00ed krize).<strong>Nitr\u00e1ty<\/strong> \u2014 pro profylaxi stabiln\u00ed anginy pectoris a akutn\u00ed z\u00e1chranu p\u0159i angin\u011b. <a href=\"https:\/\/medsbase.com\/cs\/sorbitrate\/\">Sorbitrate<\/a> (isosorbid dinitr\u00e1t) je sublingv\u00e1ln\u00ed z\u00e1chrann\u00e1 l\u00e9\u010dba plus or\u00e1ln\u00ed profylaxe. <a href=\"https:\/\/medsbase.com\/cs\/monit\/\">Monit<\/a> (isosorbidmononitr\u00e1t) je jednou denn\u011b pod\u00e1van\u00e1 profylaxe s asymetrick\u00fdm d\u00e1vkov\u00e1n\u00edm k zachov\u00e1n\u00ed nitr\u00e1tov\u00e9ho voln\u00e9ho intervalu a prevenci tolerance.<strong>Specializace: plicn\u00ed hypertenze a chronick\u00e9 srde\u010dn\u00ed selh\u00e1n\u00ed.<\/strong> <a href=\"https:\/\/medsbase.com\/cs\/ambrican\/\">Ambrican<\/a> (ambrisentan) je selektivn\u00ed antagonista endotelin-A receptoru pro plicn\u00ed arteri\u00e1ln\u00ed hypertenzi (PAH). <a href=\"https:\/\/medsbase.com\/cs\/rioci-1\/\">Rioci 1<\/a> (riociguat) je stimul\u00e1tor solubiln\u00ed guanyl\u00e1tcykl\u00e1zy pro PAH a CTEPH. <a href=\"https:\/\/medsbase.com\/cs\/ivabrad\/\">Ivabrad<\/a> (ivabradin) sni\u017euje srde\u010dn\u00ed frekvenci inhibic\u00ed funny-kan\u00e1l\u016f bez vlivu na krevn\u00ed tlak \u2014 pro chronick\u00e9 srde\u010dn\u00ed selh\u00e1n\u00ed (LVEF &lt;35%) p\u0159i maxim\u00e1ln\u011b tolerovan\u00e9 terapii betablok\u00e1tory. <a href=\"https:\/\/medsbase.com\/cs\/lonitab\/\">Lonitab<\/a> (minoxidil) je siln\u00fd arteri\u00e1ln\u00ed vazodilat\u00e1tor pro rezistentn\u00ed hypertenzi, kter\u00e1 nereaguje na t\u0159\u00edl\u00e9kovou terapii. <a href=\"https:\/\/medsbase.com\/cs\/minoxytop\/\">Minoxytop<\/a> je stejn\u00e1 molekula v n\u00edzk\u00e9 d\u00e1vce pou\u017e\u00edvan\u00e1 off-label pro androgenn\u00ed alopecii.<strong>Jak vybrat.<\/strong> Hypertenze 1. stupn\u011b (140\u2013159 \/ 90\u201399) u pacienta do 55 let \u2192 monoterapie ARB nebo ACE inhibitorem. Pacient nad 55 let nebo afrokaribsk\u00e9ho p\u016fvodu \u2192 monoterapie CCB. Hypertenze 2. stupn\u011b (\u2265160\/100) \u2192 zah\u00e1jit p\u0159\u00edmo dvoulekovou kombinaci (ARB+CCB nebo ARB+thiazid). Rezistentn\u00ed hypertenze na t\u0159ech l\u00e9c\u00edch \u2192 p\u0159idat spironolakton, pot\u00e9 alfa-blok\u00e1tor, pot\u00e9 centr\u00e1ln\u011b p\u016fsob\u00edc\u00ed l\u00e1tku. T\u011bhotenstv\u00ed \u2192 pouze labetalol, methyldopa nebo retardovan\u00fd nifedipin (ACE inhibitory a ARB absolutn\u011b kontraindikov\u00e1ny). Diabetik s proteinuri\u00ed \u2192 ARB nebo ACE inhibitor jako prvn\u00ed bez ohledu na v\u011bk. V\u0161echny l\u00e9ky na krevn\u00ed tlak od MedsBase jsou <strong>generick\u00e9 l\u00e9ky schv\u00e1len\u00e9 FDA<\/strong> vyroben\u00e9 <strong>WHO-GMP certifikovan\u00fdmi v\u00fdrobci<\/strong>. Celosv\u011btov\u00e1 doprava. V\u011brnostn\u00ed body se po\u010d\u00edtaj\u00ed u ka\u017ed\u00e9 objedn\u00e1vky.\n\n<!-- mb-hub-link --><strong>2026 buyer's guide:<\/strong> Prohl\u00e9dn\u011bte si n\u00e1\u0161 v\u00fdb\u011br <a href=\"\/cs\/best-blood-pressure-medications-2026\/\">Nejlep\u0161\u00ed l\u00e9ky na krevn\u00ed tlak pro rok 2026<\/a> pro se\u0159azen\u00e9 tipy, srovn\u00e1vac\u00ed tabulku, d\u00e1vkov\u00e1n\u00ed a zkratku k rozhodnut\u00ed.","link":"https:\/\/medsbase.com\/cs\/high-blood-pressure-medication\/","name":"L\u00e9ky na vysok\u00fd krevn\u00ed tlak","slug":"high-blood-pressure-medication","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product?product_cat=3356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}